VBP
New drug pricing plans will ‘damage UK biotech’
August 16, 2013Research and Development, Sales and Marketing BIA, Hunt, NHS, VBP, bates, biotech
The BioIndustry Association is warning that the government’s new drug pricing scheme could put future investment in the UK’s biotech …
UK government keen to reduce drugs bill
June 21, 2013Sales and Marketing NHS, NICE, UK, VBP
The government has shown its hand in the drug pricing debate after asking for a 20% price cut on some …
VBP will be ‘unfair’: report
May 8, 2013Medical Communications, Research and Development, Sales and Marketing 2020health, ABPI, NHS, VBP
A new report on value-based pricing (VBP) concludes that the new system will be unfair to patients and says the …
NICE to assess drug value
March 22, 2013Sales and Marketing EMIG, NHS, NICE, VBP
NICE will be responsible for assessing the full value of medicines – taking into account their benefit to patients and …
UCB warns of data ‘voyeurism’
February 27, 2013Research and Development, Sales and Marketing EFPIA, UCB, VBP, transparancy
UCB chief executive Roch Doliveux has attacked the idea of making all clinical trial data publicly available, saying it could …
VBP negotiations ‘opened up’
February 19, 2013Sales and Marketing ABPI, Cancer, EMIG, NHS, VBP
Patient views will for the first time be heard in negotiations between the Department of Health and ABPI about Value-Based …
Delivering value in cost-constrained healthcare environments
February 14, 2013Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Cost, MSI, NHS, VBP, austerity, value
As millions of pounds, euros and dollars are cut from healthcare budgets around the world – driven by austerity measures …
Scotland’s medicines bill can shrink further, says report
January 25, 2013Sales and Marketing PPRS, Scotland, VBP, prescribing
An official review of primary care prescribing in Scotland has welcomed savings made, but says further efficiencies are possible.Audit Scotland …
MPs: ‘get on with VBP’
January 18, 2013Medical Communications, Sales and Marketing NHS, NICE, PPRS, VBP
An influential group of MPs has hit out at inactivity over moves towards value-based pricing (VBP), saying that the issue …
The price of innovation
January 16, 2013Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ABPI, NHS, NICE, Rose, VBP
One of the strange paradoxes of our industry is that we have a very large number of new medicines in …
NICE: ‘lot of work’ to do on VBP
November 30, 2012Medical Communications, Sales and Marketing Boysen, NHS, NICE, QALY, VBP
NICE is still working out what its role with the new NHS Commissioning Board will be, with other key issues …
Patients ‘shut out’ of drug price talks
November 13, 2012Sales and Marketing Cancer, NHS, NICE, VBP, prostate
Patients are being excluded from the negotiations between government and the pharma industry on the introduction of Value-Based Pricing (VBP).That …
NHS prescribing costs fall
October 22, 2012Sales and Marketing NHS, VBP, prescribing
The Department of Health’s annual report and accounts for 2011-2012 highlights the increasing pressure on the pharma industry to deliver …
NICE bows to industry pressure
August 21, 2012Sales and Marketing ABPI, NICE, QALY, VBP
NICE has bowed to industry pressure and will allow independent advisors to sit on its appeals board. An appeal can …
ABPI appoints UK pharma team to head VBP discussion
August 8, 2012Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ABPI, VBP
The ABPI has announced the team which will represent the pharma industry in negotiations with the government to agree the …
Latest content
Santen joins inaugural Global Summit for Eye Health as partner
